Skip to main content

Table 1 Patient demographics and Histopathologies

From: Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival

Age at Diagnosis

 

   Median (Range)

66 (26 - 86)

   25th to 75th Percentile

60 - 73

Sex

 

   Male

175 (47%)

   Female

197 (53%)

Smoking History

 

   Current Smoker

53 (14%)

   Previously Smoked

257 (69%)

   Second-Hand Smoke

11 (3%)

   Non-Smoker

39 (11%)

   Unknown

12 (3%)

Histology

 

   Adenocarcinoma

222 (60%)

   Squamous Cell Carcinoma

106 (29%)

   Adenosquamous Carcinoma

20 (5%)

   Bronchioloalveolar Carcinoma

24 (6%)

Clinical Stage

 

   I

209 (56%)

   II

68 (18%)

   III

69 (19%)

   IV

24 (6%)

   Unknown

2 (1%)

Tumor Grade

 

   1

64 (17%)

   2

119 (32%)

   3

161 (43%)

   Unknown

28 (8%)

Tumor Size (cm)

 

   Median (Range)

3.6 (0.4 - 15.0)

   25th to 75th Percentile

2.0 - 4.7

Lymph Node Metastases

 

   Absent

224 (60%)

   Present

104 (28%)

   Unknown

44 (12%)

Distant Metastases

 

   Absent

274 (74%)

   Present

24 (6%)

   Unknown

74 (20%)